Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Small molecule CCR5 inhibitor tested against SIV

Jan. 16, 2004

Gilead submits IND for novel HIV protease inhibitor GS-9005

Jan. 14, 2004

Targeted Genetics extends AIDS vaccine partnership

Jan. 13, 2004

FDA approval for Invirase boosted with ritonavir for HIV

Jan. 9, 2004

Roche and Trimeris to develop next generation of HIV fusion inhibitors

Jan. 8, 2004

Japanese launch for Reyataz

Jan. 8, 2004

New macrocyclic anti-HIV agents in early development at AIDS Care Pharma

Jan. 8, 2004

Strategic alliance and IND plans for new DNA-based HIV vaccine

Jan. 5, 2004

Phase I trial of VRX-496 modified T-cells continues with third patient

Dec. 23, 2003

Fuzeon 48-week data submitted to support full FDA approval

Dec. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...